Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and…
NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke NeuWire Medical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the…
SOLVE FSHD Accelerates Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD SOLVE FSHD announced new nonclinical data supporting SFH-4090 for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The data were presented at the 31st Annual Congress of the World…
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP TriLink BioTechnologies, LLC a Maravai LifeSciences company and global provider of life science reagents and services, announced it has been granted a…
Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies Kincell Bio and Cellipont Bioservices announced the completion of their merger to form Kincellis Advanced Therapies a U.S.-based contract development and manufacturing organization focused on cell therapies and other…
AESARA Appoints Denise Sánchez as Vice President, Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served…
Cronus Pharma Launches First FDA-Approved Bioequivalent Robenacoxib Injection for Veterinary Use Cronus Pharma LLC, a veterinary pharmaceutical company focused on developing high-quality, cost-effective animal health products, today announced the U.S. launch of Robenacoxib Injection, the only FDA-approved bioequivalent to ONSIOR® (robenacoxib)…
Carna Health and Level Up Sign a Memorandum of Understanding to Advance Preventive Healthcare in Kazakhstan Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, announced the signing of a Memorandum of Understanding (MOU) with Level Up to…
H.B. Fuller Announces AMS Shareholders Approve Proposed Acquisition H.B. Fuller Company the world’s largest pureplay adhesives company, today announced that shareholders of Advanced Medical Solutions Group plc (“AMS”) (LSE:AMS) approved H.B. Fuller’s proposed acquisition of AMS at specially convened meetings…
Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth Applied BioCode, Inc., a leader in high-throughput multiplex molecular diagnostics, announced financial results for the…
Propel Software Launches Manufacturing Hub Providing Seamless and Standardized Integration with 12 ERP Platforms Propel, creator of the first product value management (PVM) platform to transform how manufacturers develop, launch, and service products, today announced its Summer 2026 release highlighted…
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery IQVIA a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, and Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company pioneering…